和血明目片治疗视网膜静脉阻塞的临床观察

Clinical observation of hexuemingmu tablet on retinal vein occlusion

目的:探讨和血明目片对视网膜静脉阻塞(ROV)的疗效。方法:我院收治的视网膜静脉阻塞患者108例112眼,随机分为2组进行治疗。观察组为和血明目片口服(55例55眼),对照组静脉滴注丹红注射液(53例57眼)。观察两组治疗前后的视力、眼底和眼底荧光血管造影(FFA)。结果:观察组治疗视网膜静脉阻塞总有效率98%,对照组总有效率82%。出血较对照组吸收快。经统计学分析,有统计学差异(P<0.05)。结论:和血明目片治疗视网膜静脉阻塞疗效显著,较好的促进视网膜出血的吸收,有效的改善患者视力。

AIM： To evaluate the effect of hexuemingmu tablet on retinal vein occlusion （ ROV） . METHODS： Totally, 108 patients of 112 eyes were divided into two groups randomly. One group including 55 patients （ 55 eyes ） were treated by hexuemingmu tablet, the other group including 53 patients （ 57 eyes ） were treated by danhong injection. The visual acuity, fundus and FFA were evaluated before and after treatment. RESULTS： The total effective rate in the group treated by hexuemingmu tablet was 98%, and that in control group was 82%. The hemorrhage was absorbed much more quickly than control group. Two group were different from each other in statistics （P〈0. 05）. CONCLUSION： Hexuemingmu tablet can accelerate hemorrhage absorbing and improve visual acuity in RVO treatment.